NEW YORK, Feb 1 – Illumigen Biosciences, a start-up applied genomics company in Seattle, Wash., has unveiled a new computing platform for analyzing the human genome, the company said Thursday.

The system, GeneLamp, compares experimental data from Illumigen’s in-house laboratories with data from “a variety” of genomics databases to search for drug targets, according to the company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.